Hutchinson Capital Management’s GSK GSK Stock Holding History

Hutchinson Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,947	Closed	-$214K	–	50
2016 Q2	$214K	Hold	3,947	–	–	0.06%	51
2016 Q1	$200K	Buy	+3,947	New	+$197K	0.06%	53
2015 Q3	–	Sell	-3,947	Closed	-$206K	–	54
2015 Q2	$206K	Hold	3,947	–	–	0.06%	53
2015 Q1	$228K	Hold	3,947	–	–	0.07%	54
2014 Q4	$211K	Hold	3,947	–	–	0.06%	61
2014 Q3	$227K	Hold	3,947	–	–	0.07%	56
2014 Q2	$264K	Hold	3,947	–	–	0.07%	54
2014 Q1	$264K	Hold	3,947	–	–	0.08%	49
2013 Q4	$263K	Hold	3,947	–	–	0.08%	51
2013 Q3	$248K	Hold	3,947	–	–	0.08%	52
2013 Q2	$247K	Buy	+3,947	New	+$251K	0.08%	51

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Hutchinson Capital Management's GSK Position: Q3 2016 in Review

Hutchinson Capital Management sold out of GSK (GSK) in Q3 2016, closing a stake of 3,947 shares — an estimated $214K sold.

Hutchinson Capital Management first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $264K in Q2 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Hutchinson Capital Management reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
Hutchinson Capital Management sold 3,947 GSK shares in Q3 2016, an estimated $214K.
Hutchinson Capital Management first reported a position in GSK in Q2 2013 and held it in 11 quarters.
Hutchinson Capital Management's GSK position peaked at $264K in Q2 2014.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Hutchinson Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.